• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Contamination /Decontamination Problem (2895)
Patient Problem Unspecified Infection (1930)
Event Date 09/24/2017
Event Type  Injury  
Manufacturer Narrative
The section were completed with the provided mean age and mean gender of the article.Section was completed with the date when the article was accepted as individual date of event was not stated in article.Viabahn stent for hemodialysis shunt: efficacy, long segment recanalization and prognostic factors for reintervention, published by giancarlo salsano et al, published in the journal of vascular access 2018, vol.19(1)76-83.
 
Event Description
Within the article ¿viabahn stent for hemodialysis shunt: efficacy, long segment recanalization and prognostic factors for reintervention¿, published by giancarlo salsano et al, within the journal of vascular access, the article indicates the following: the study evaluated the heparin bioactive surface (hbs) viabahn stent efficacy in the maintenance or re-establishment of hemodialysis.In total 50 viabahn stents deployed in 37 consecutive patients with hemodialysis dysfunction from january 2008 to may 2016 were evaluated in a single-institution retrospective review.In our series, 23 patients underwent multiple endovascular procedures after the stent placement in the whole period of follow-up.The endovascular procedures included angioplasty, thrombo-aspiration and a second viabahn stenting.The article describes a single case of infection of avg by staphylococcus aureus occurred three months after the stent placement.
 
Manufacturer Narrative
Code correction for previous reported ¿result code 1¿ 142.The code was exchanged to 3221.¿conclusion code 1¿ was also exchanged from 11 to 4315.Added another "method code 1".
 
Manufacturer Narrative
Multiple attempts have been made from the gore associate to the complainant in order to get additional information.As no further information related to this complaint will be provided by the complainant, this event will be closed with the information received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10023272
MDR Text Key194322003
Report Number2017233-2020-00311
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup,Followup
Report Date 07/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age71 YR
-
-